Jacqueline Mercier

Royalty Monetization In An Era Of Drug Pricing Pressure: How The IRA Is Affecting Royalty Monetizations

To Monetize Or Not To Monetize? The Question Late-Stage Life Sciences Companies Should Be Asking

The Continued Rise Of Royalty Deals In Life Sciences